NIH-funded research R01 grant

Exploring the role of BNP in cardiovascular disease beyond its use as a biomarker

Official title: BNP not just a biomarker of cardiovascular disease

Funded at Texas A&m University Health Science Ctr · NIH-11030796 · Data updated 2026-11-12

This study is looking at how a substance called B-type natriuretic peptide (BNP) can help doctors understand heart failure better and see if it plays a role in making heart problems worse, so if you're dealing with heart issues, you might have a chance to participate and help us learn more about your condition.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas A&m University Health Science Ctr
NIH-funded
Lab location1 site (College Station, United States)
Project startFebruary 15, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$463,480
NIH project number5R01HL167767-02
Project IDNIH-11030796 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals diagnosed with heart failure or acute coronary syndrome who are being monitored for BNP levels.

Less likely to help

Patients with non-cardiovascular conditions or those not exhibiting elevated BNP levels may not benefit from this research.

What this research studies

This research investigates the dual role of B-type natriuretic peptide (BNP) in cardiovascular disease, focusing on its function as both a diagnostic biomarker and a potential contributor to disease progression. The study will analyze how BNP levels correlate with heart failure severity and the risk of adverse cardiovascular events, such as myocardial infarction. By examining the effects of BNP on thrombus formation and platelet aggregation in both animal models and human subjects, the research aims to uncover new insights into the mechanisms of cardiovascular disease. Patients may be involved in trials assessing BNP's impact on their condition and treatment outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of cardiovascular diseases, potentially enhancing treatment strategies for patients.

How similar studies have gone: Preliminary studies have shown promising results regarding BNP's role in thrombus formation, suggesting that this research builds on existing findings rather than exploring a completely novel area.

Where this research is happening

  • Texas A&m University Health Science Ctr
    College Station, United States
    Active

Researchers

  • Principal investigator: Li, Zhenyu — Texas A&m University Health Science Ctr
  • Study coordinator: Li, Zhenyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.